Stryker stock steadies after target cuts and earnings gains

Published on 09/23/2026 at 10:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker stock closed at USD 275.09 on September 22, 2026, after a 0.33 percent gain. Second-quarter revenue rose 9.4 percent to USD 6.59 billion.

Fotorealistischer OP-Saal mit robotergestützter Chirurgie und sterilen Instrumenten — Fotorealistische Operationssaal-Szene veranschaulicht Stryker Corp. US8636671013 mit robotergestützter Chirurgie und moderner Medizintechnik-Ausstattung, Illustration mit AI erstellt.

Stryker Corp. (ISIN US8636671013) closed at USD 275.09 on the NYSE on September 22, 2026, up 0.33 percent from the prior close. The move followed a sharp valuation reset: Investing.com reported on September 22, 2026, that TD Cowen lowered its price target from USD 355 to USD 298 while retaining a Hold rating.

Target spread widens

The revised TD Cowen target is USD 57 below the previous target, a reduction of 16.1 percent. Trading data placed the stock USD 8.09 above its reported 52-week low of USD 267 on September 22, 2026, leaving execution and margin delivery central to the valuation debate.

The analyst view is divided. Investing.com reported on September 22, 2026, that Wolfe Research raised its target to USD 375 after strong second-quarter results, while Citizens cut its target to USD 400 because of operational disruptions including a cyberattack and supply-chain issues.

Revenue growth meets execution risk

Stryker's second-quarter 2026 revenue reached USD 6.59 billion, up 9.4 percent from the same quarter a year earlier, according to MarketBeat in a September 22, 2026 filing report. Adjusted earnings were USD 3.69 per share, USD 0.20 above the USD 3.49 consensus estimate, while the prior-year figure was USD 3.13.

The same report showed fiscal 2026 earnings guidance of USD 14.950 to USD 15.100 per share. That guidance provides a measurable counterweight to the lower target, but the cited analyst revisions indicate that investors are weighing growth against gross-margin pressure and manufacturing disruptions.

Stock remains near yearly low

Stryker stock stood at USD 275.09 on the NYSE at the September 22, 2026 close, with a daily gain of 0.33 percent and a reported 52-week low of USD 267. The stock was down 21.6 percent year to date in the September 21, 2026 market snapshot, making the distance between operating growth and valuation sentiment unusually visible.